Department of Cancer Imaging, 3085Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Sir Peter MacCallum Department of Oncology, 2281The University of Melbourne, Parkville, VIC, Australia.
Neuroradiol J. 2023 Apr;36(2):169-175. doi: 10.1177/19714009221114440. Epub 2022 Jul 10.
Volumetric turbo spin echo (3D-TSE) T1-weighted imaging techniques such as T1-SPACE (Sampling Perfection with Application optimized Contrasts by using different flip angle Evolutions) improve detection of intracranial metastases (IM) compared to volumetric magnetisation-prepared gradient recalled echo techniques such as MPRAGE (Magnetization-Prepared Rapid Acquisition with Gradient Echo). However, incomplete vascular suppression can produce false positives when using 3D-TSE. Research into 3D-TSE has generally targeted patients with known or suspected IM, but the clinical implications of false positives are greater in patients with lower likelihood of IM. This study examined additional findings identified by T1-SPACE in patients with metastatic melanoma, targeting patients with a lower incidence of IM.
Patients with metastatic melanoma and an upcoming brain MRI booking were identified prospectively. Consent for adding post-contrast T1-SPACE to the MRI protocol (which included MPRAGE) was obtained. Imaging was initially assessed without T1-SPACE. Subsequently, T1-SPACE images were examined and additional findings identified were recorded, including their correlation with MPRAGE.
One hundred examinations were performed, 24 having evidence of active IM. T1-SPACE allowed identification of additional lesions in five patients, including two with small solitary IM not identified when first assessing MPRAGE. In 18 examinations, T1-SPACE identified additional equivocal findings, confidently attributed to artefact (most commonly normal vessels) following correlation with MPRAGE.
T1-SPACE improves detection of small lesions in patients without known IM, changing patient management. False positives are common but can be clarified with MPRAGE. Combining T1-SPACE and MPRAGE allows both sensitivity and specificity to be optimised.
与体积磁化准备梯度回波技术(如 MPRAGE)相比,容积涡轮自旋回波(3D-TSE)T1 加权成像技术(如 T1-SPACE,采用不同翻转角演化的应用优化对比采样完美)可提高颅内转移瘤(IM)的检测率。然而,使用 3D-TSE 时,不完全的血管抑制会产生假阳性。3D-TSE 的研究通常针对已知或疑似有 IM 的患者,但在 IM 可能性较低的患者中,假阳性的临床意义更大。本研究在转移性黑色素瘤患者中检查了 T1-SPACE 识别的其他发现,目标是 IM 发生率较低的患者。
前瞻性地确定患有转移性黑色素瘤且即将进行脑部 MRI 检查的患者。获得了对 MRI 方案(包括 MPRAGE)添加对比后 T1-SPACE 的同意。最初在没有 T1-SPACE 的情况下评估成像。随后,检查 T1-SPACE 图像并记录识别出的其他发现,包括与 MPRAGE 的相关性。
共进行了 100 次检查,其中 24 次有活动性 IM 的证据。T1-SPACE 允许在五名患者中识别出其他病变,包括两名患者在首次评估 MPRAGE 时未发现的小孤立性 IM。在 18 次检查中,T1-SPACE 识别出其他可疑发现,在与 MPRAGE 相关联后,明确归因于伪影(最常见的是正常血管)。
T1-SPACE 可提高对无已知 IM 的患者的小病变的检出率,从而改变患者的治疗管理。假阳性很常见,但可以通过 MPRAGE 来澄清。T1-SPACE 和 MPRAGE 的结合可优化敏感性和特异性。